Neuropace Stock Technical Analysis
| NPCE Stock | USD 10.25 0.05 0.49% |
As of the 28th of November, Neuropace secures the Mean Deviation of 3.46, risk adjusted performance of 0.0762, and Downside Deviation of 3.5. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neuropace, as well as the relationship between them. Please verify Neuropace value at risk, as well as the relationship between the semi variance and kurtosis to decide if Neuropace is priced some-what accurately, providing market reflects its recent price of 10.25 per share. Given that Neuropace has jensen alpha of 0.1796, we recommend you to check Neuropace's last-minute market performance to make sure the company can sustain itself at a future point.
Neuropace Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Neuropace, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NeuropaceNeuropace |
Neuropace Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 7.8 | Strong Buy | 7 | Odds |
Most Neuropace analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Neuropace stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Neuropace, talking to its executives and customers, or listening to Neuropace conference calls.
Neuropace technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Neuropace Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Neuropace volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Neuropace Trend Analysis
Use this graph to draw trend lines for Neuropace. You can use it to identify possible trend reversals for Neuropace as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Neuropace price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Neuropace Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Neuropace applied against its price change over selected period. The best fit line has a slop of 0.04 , which means Neuropace will continue generating value for investors. It has 122 observation points and a regression sum of squares at 47.92, which is the sum of squared deviations for the predicted Neuropace price change compared to its average price change.About Neuropace Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Neuropace on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Neuropace based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Neuropace price pattern first instead of the macroeconomic environment surrounding Neuropace. By analyzing Neuropace's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Neuropace's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Neuropace specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 8.53 | 6.07 | 7.42 | 9.92 | Days Of Inventory On Hand | 243.02 | 272.12 | 236.61 | 276.82 |
Neuropace November 28, 2024 Technical Indicators
Most technical analysis of Neuropace help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neuropace from various momentum indicators to cycle indicators. When you analyze Neuropace charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0762 | |||
| Market Risk Adjusted Performance | 0.2069 | |||
| Mean Deviation | 3.46 | |||
| Semi Deviation | 3.15 | |||
| Downside Deviation | 3.5 | |||
| Coefficient Of Variation | 1129.79 | |||
| Standard Deviation | 5.33 | |||
| Variance | 28.46 | |||
| Information Ratio | 0.0641 | |||
| Jensen Alpha | 0.1796 | |||
| Total Risk Alpha | (0.38) | |||
| Sortino Ratio | 0.0976 | |||
| Treynor Ratio | 0.1969 | |||
| Maximum Drawdown | 35.38 | |||
| Value At Risk | (6.19) | |||
| Potential Upside | 9.73 | |||
| Downside Variance | 12.26 | |||
| Semi Variance | 9.9 | |||
| Expected Short fall | (4.25) | |||
| Skewness | 2.43 | |||
| Kurtosis | 10.29 |
Complementary Tools for Neuropace Stock analysis
When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |